Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cristina Mullenix

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Mediastinum (Hong Kong, China)|September 27, 2022
Distinguishing between thymic carcinoma and lung carcinoma: a medical oncologist's perspectiveArun Rajan, Cristina Mullenix, Meredith J McAdams
Mediastinum (Hong Kong, China)|September 20, 2021
The role of immunotherapy for management of advanced thymic epithelial tumors: a narrative reviewArun Rajan, Cristina Mullenix, Meenakshi Shelat, et al.
JTO Clinical and Research Reports|December 27, 2021
Reply to K. Takada et alMadison Ballman, Cristina Mullenix, Eva Szabo, et al.
JTO Clinical and Research Reports|September 13, 2021
Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial TumorsMadison Ballman, Shannon Swift, Cristina Mullenix, et al.
The Oncologist|April 5, 2022
Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial TumorsCristina Mullenix, Madison Ballman, Haobin Chen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Mediastinum (Hong Kong, China)|September 27, 2022
Distinguishing between thymic carcinoma and lung carcinoma: a medical oncologist's perspectiveArun Rajan, Cristina Mullenix, Meredith J McAdams
Mediastinum (Hong Kong, China)|September 20, 2021
The role of immunotherapy for management of advanced thymic epithelial tumors: a narrative reviewArun Rajan, Cristina Mullenix, Meenakshi Shelat, et al.
JTO Clinical and Research Reports|December 27, 2021
Reply to K. Takada et alMadison Ballman, Cristina Mullenix, Eva Szabo, et al.
JTO Clinical and Research Reports|September 13, 2021
Tolerability of Coronavirus Disease 2019 Vaccines, BNT162b2 and mRNA-1273, in Patients With Thymic Epithelial TumorsMadison Ballman, Shannon Swift, Cristina Mullenix, et al.
The Oncologist|April 5, 2022
Joint-Predominant Rheumatic Complications of Immune Checkpoint Inhibitor Therapy in Patients with Thymic Epithelial TumorsCristina Mullenix, Madison Ballman, Haobin Chen, et al.
Pageof 1